Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chiesi Takes Aim At Next-Generation Eosinophilic Asthma Therapy

Nov 21 2016

• By John Davis

Related Content

Cornerstone accepts Chiesi proposal after long courtship

Sep 17 2013

Chiesi Buys Denmark’s Zymenex For Phase III Enzyme Replacement Therapy

Aug 27 2013

Teva Under Pressure As NICE Calls For More Reslizumab Analyses

Nov 15 2016

Why AZ Respiratory Head Believes Third-Placed Benralizumab Can Conquer Market

Sep 07 2016

Related Companies

Chiesi Farmaceutici S.p.A.

Novartis AG

Merck & Co., Inc.

AstraZeneca PLC

GSK plc

Teva Pharmaceutical Industries Ltd.

Novartis AG

Gossamer Bio, Inc.

Merck & Co., Inc.

Panmira Pharmaceuticals, LLC.

Array BioPharma, Inc.

Boehringer Ingelheim GmbH

Cornerstone Pharmaceuticals, Inc.

Additional Topics

M & A Deals Commercial Respiratory BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window